- 2024-08-20 02:18抑制剂Yibeissine|Yibeissine|143502-51-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:18抑制剂Yibeissine|Yibeissine|143502-51-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂XY028-140|XY028-140|2229974-83-6|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:18抑制剂XY028-140|XY028-140|2229974-83-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂XY028-140|XY028-140|2229974-83-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂XMD-17-51|XMD-17-51|1628614-50-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂XMD-17-51|XMD-17-51|1628614-50-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂XRK3F2|XRK3F2|2375193-43-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂XY028-133|XY028-133|2229974-73-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂XL413|XL413|1169558-38-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂XL413|XL413|1169558-38-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂XMD-17-51|XMD-17-51|1628614-50-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:18抑制剂XL413 hydrochloride|XL413 hydrochloride|2062200-97-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:18抑制剂XL413 hydrochloride|XL413 hydrochloride|2062200-97-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂XL413 hydrochloride|XL413 hydrochloride|2062200-97-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂XL413|XL413|1169558-38-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:18抑制剂XL228|XL228|898280-07-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:18抑制剂XL228|XL228|898280-07-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂XL228|XL228|898280-07-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂Xevinapant hydrochloride|Xevinapant hydrochloride|1071992-57-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
